RS

Ron Seubert

North America, Washington, United States, Seattle

Description

Ron Seubert is the founder, President, and CEO of RareCyte. Previously Ron was co-founder of both Applied Precision LLC and Applied Precisio...

Investor Profile

Ron Seubert has made 4 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (50%)
  • Series G (25%)
  • Series F (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ron Seubert frequently co-invest with?

5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 4
SC
North America, New York, United States, Florida
Co-Investments: 1
HealthQuest Capital
North America, California, United States, Redwood City
Co-Investments: 3
G
North America, Delaware, United States, Wilmington
Co-Investments: 1
Agilent Technologies
North America, California, United States, Santa Clara
Co-Investments: 2
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
TH
North America, California, United States, San Francisco
Co-Investments: 1
The Forest Road Company
North America, New York, United States, New York
Co-Investments: 1
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 1
Arboretum Ventures
North America, Michigan, United States, Ann Arbor
Co-Investments: 2

What are some of recent deals done by Ron Seubert?

RareCyte

Seattle, Washington, United States

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series UnknownJun 27, 2024
Amount Raised: $20,000,000
RareCyte

Seattle, Washington, United States

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series GSep 9, 2021
Amount Raised: $24,000,000
RareCyte

Seattle, Washington, United States

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series FDec 19, 2019
Amount Raised: $22,000,000
RareCyte

Seattle, Washington, United States

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series UnknownAug 29, 2017
Amount Raised: $30,000,000